← Back to Search

Watermelon for High Blood Pressure (WMBP Trial)

N/A
Waitlist Available
Led By Indika Edirisinghe, Ph.D.
Research Sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Fasting blood glucose concentration between 100 mg/dL and 125 mg/dL at screening visit (value range indicate prediabetes, by finger prick and/or venous blood sampling)
Have no clinical evidence/history of cardiovascular, metabolic, respiratory, renal, gastrointestinal, or hepatic disease
Must not have
Men and women who have fasting blood glucose concentration <100 or >125 mg/dL at screening visit
Have cancer other than non-melanoma skin cancer in previous 5 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 4 weeks

Summary

This trial studies how watermelon can help regulate blood pressure in people with pre-hypertension and its effects on other health factors.

Who is the study for?
This trial is for healthy overweight/obese adults aged 25-65 with slightly elevated blood pressure but no history of serious health issues. Participants should be nonsmokers, not on a vegetarian diet, and have stable weight without plans to lose more. They shouldn't consume certain supplements or medications that affect blood pressure or metabolism.
What is being tested?
The study tests how different amounts of watermelon flesh impact blood pressure in people with pre-hypertension. It also looks at the effects on heart-related risk factors like cholesterol and metabolic markers. Participants will receive one of two doses of watermelon flesh or a control treatment.
What are the potential side effects?
Since the intervention involves consuming watermelon, side effects are expected to be minimal but may include food-related allergies or intolerances for those sensitive to ingredients in the study's diet.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My fasting blood sugar is between 100 and 125 mg/dL, indicating prediabetes.
Select...
I have no history of major organ or metabolic diseases.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My fasting blood sugar is either below 100 or above 125 mg/dL.
Select...
I have not had any cancer except for non-melanoma skin cancer in the last 5 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To evaluate the change in the dose response effects of watermelon flesh in regulating BP in individuals with pre-hypertension.
Secondary study objectives
To evaluate the change in glucose in individuals with pre-hypertension after consuming watermelon flesh.
To evaluate the change in insulin in individuals with pre-hypertension after consuming watermelon flesh.
To evaluate the change in lipid profile in individuals with pre-hypertension after consuming watermelon flesh.
+2 more

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Watermelon flesh Dose 1Active Control1 Intervention
1 cup watermelon flesh, \~152 g
Group II: Watermelon flesh Dose 2Active Control1 Intervention
2 cups watermelon flesh, \~304 g
Group III: ControlPlacebo Group1 Intervention
Calorie-matched control beverage

Find a Location

Who is running the clinical trial?

Clinical Nutrition Research Center, Illinois Institute of TechnologyLead Sponsor
54 Previous Clinical Trials
2,964 Total Patients Enrolled
National Watermelon Promotion BoardOTHER
1 Previous Clinical Trials
23 Total Patients Enrolled
Indika Edirisinghe, Ph.D.Principal InvestigatorIllinois Institute of Technology

Media Library

Watermelon Flesh Clinical Trial Eligibility Overview. Trial Name: NCT05892328 — N/A
Cardiovascular Disease Research Study Groups: Control, Watermelon flesh Dose 1, Watermelon flesh Dose 2
Cardiovascular Disease Clinical Trial 2023: Watermelon Flesh Highlights & Side Effects. Trial Name: NCT05892328 — N/A
Watermelon Flesh 2023 Treatment Timeline for Medical Study. Trial Name: NCT05892328 — N/A
~13 spots leftby Dec 2025